Genmab A/S
Patents, Design & Utilities
Last updated:
List of all Genmab A/S patents 89 in total
| Status | Patent |
|---|---|
Application | Utility: AXL ANTIBODY-DRUG CONJUGATES FOR USE IN TREATING CANCER Filling date: 26 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES Filling date: 26 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: ANTIBODIES AGAINST HUMAN CD38 Filling date: 26 Sep 2025 Issue date: 30 Jun 2022 |
Grant | Utility: Humanized or chimeric CD3 antibodies Filling date: 26 Sep 2025 Issue date: 14 Jun 2022 |
Application | Utility: POTENCY ASSAYS FOR ANTIBODY DRUG SUBSTANCE BINDING TO AN FC RECEPTOR Filling date: 26 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: MONOCLONAL ANTIBODIES AGAINST HER2 Filling date: 26 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING FOLLICULAR LYMPHOMA Filling date: 26 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: METHOD FOR TREATING CANCER Filling date: 26 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA Filling date: 26 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA Filling date: 26 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING FOLLICULAR LYMPHOMA Filling date: 26 Sep 2025 Issue date: 14 Apr 2022 |
Grant | Utility: Antibodies Filling date: 26 Sep 2025 Issue date: 1 Mar 2022 |
Application | Utility: ANTIBODIES Filling date: 26 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: ANTIBODIES Filling date: 26 Sep 2025 Issue date: 17 Feb 2022 |
Grant | Utility: Antibodies against human CD38 Filling date: 26 Sep 2025 Issue date: 25 Jan 2022 |
Application | Utility: METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-VEGF ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE Filling date: 26 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR Filling date: 26 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: AXL-SPECIFIC ANTIBODIES FOR TREATMENT OF NON-SMALL CELL LUNG CANCER Filling date: 26 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 Filling date: 26 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: BISPECIFIC ANTIBODIES AGAINST HER2 Filling date: 26 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER Filling date: 26 Sep 2025 Issue date: 7 Oct 2021 |
Grant | Utility: Antibodies Filling date: 26 Sep 2025 Issue date: 28 Sep 2021 |
Application | Utility: ANTIBODIES Filling date: 26 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF Filling date: 26 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: METHOD FOR PRODUCING A CONTROLLED MIXTURE OF TWO OR MORE DIFFERENT ANTIBODIES Filling date: 26 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: AGONISTIC TNF RECEPTOR BINDING AGENTS Filling date: 26 Sep 2025 Issue date: 19 Aug 2021 |
Grant | Utility: Monoclonal antibodies against HER2 Filling date: 26 Sep 2025 Issue date: 17 Aug 2021 |
Grant | Utility: Methods of producing multispecific antibodies against CD40 and CD137 Filling date: 26 Sep 2025 Issue date: 17 Aug 2021 |
Grant | Utility: Multispecific antibodies against CD40 and CD137 Filling date: 26 Sep 2025 Issue date: 10 Aug 2021 |
Application | Utility: ANTIBODIES Filling date: 26 Sep 2025 Issue date: 29 Jul 2021 |
Grant | Utility: Monoclonal antibodies against HER2 Filling date: 26 Sep 2025 Issue date: 29 Jun 2021 |
Application | Utility: ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER Filling date: 26 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF Filling date: 26 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: ANTIBODY VARIANTS HAVING MODIFICATIONS IN THE CONSTANT REGION Filling date: 26 Sep 2025 Issue date: 27 May 2021 |
Grant | Utility: Antibodies Filling date: 26 Sep 2025 Issue date: 18 May 2021 |
Application | Utility: MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE Filling date: 26 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: HUMAN MONOCLONAL ANTIBODIES AGAINST CD25 Filling date: 26 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE Filling date: 26 Sep 2025 Issue date: 15 Apr 2021 |
Grant | Utility: Binding agents binding to PD-L1 and CD137 and use thereof Filling date: 26 Sep 2025 Issue date: 6 Apr 2021 |
Application | Utility: ANTIBODIES Filling date: 26 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: AXL-SPECIFIC ANTIBODIES FOR CANCER TREATMENT Filling date: 26 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: STABLE IgG4 ANTIBODIES Filling date: 26 Sep 2025 Issue date: 4 Mar 2021 |
Grant | Utility: Agonistic tumor necrosis factor (TNF) receptor binding agents Filling date: 26 Sep 2025 Issue date: 23 Feb 2021 |
Application | Utility: ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER Filling date: 26 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTIBODIES DIRECTED AGAINST CD3 AND CD20 AND THEIR USES Filling date: 26 Sep 2025 Issue date: 4 Feb 2021 |
Grant | Utility: Bispecific antibodies and methods for production thereof Filling date: 26 Sep 2025 Issue date: 2 Feb 2021 |
Application | Utility: METHODS OF TREATING CANCER WITH A COMBINATION OF A PLATINUM-BASED AGENT AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE Filling date: 26 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT Filling date: 26 Sep 2025 Issue date: 24 Dec 2020 |
Grant | Utility: Rodent bispecific heterodimeric proteins Filling date: 26 Sep 2025 Issue date: 15 Dec 2020 |
Showing 1 to 50 of 89 patents.